Style | Citing Format |
---|---|
MLA | Garajei A, et al.. "Evaluation of the Expression Levels of Mir-21-5P and Mir-429 Genes in Biopsy Samples From Patients With Oral Squamous Cell Carcinoma." Diagnostics, vol. 13, no. 7, 2023, pp. -. |
APA | Garajei A, Allameh A, Azadi M, Emami A, Atashbasteh M, Mostafavi M, Ghaderi B, Inchingolo F, Sadeghi M, Tadakamadla SK, Mohammadi H, Tadakamadla J (2023). Evaluation of the Expression Levels of Mir-21-5P and Mir-429 Genes in Biopsy Samples From Patients With Oral Squamous Cell Carcinoma. Diagnostics, 13(7), -. |
Chicago | Garajei A, Allameh A, Azadi M, Emami A, Atashbasteh M, Mostafavi M, Ghaderi B, et al.. "Evaluation of the Expression Levels of Mir-21-5P and Mir-429 Genes in Biopsy Samples From Patients With Oral Squamous Cell Carcinoma." Diagnostics 13, no. 7 (2023): -. |
Harvard | Garajei A et al. (2023) 'Evaluation of the Expression Levels of Mir-21-5P and Mir-429 Genes in Biopsy Samples From Patients With Oral Squamous Cell Carcinoma', Diagnostics, 13(7), pp. -. |
Vancouver | Garajei A, Allameh A, Azadi M, Emami A, Atashbasteh M, Mostafavi M, et al.. Evaluation of the Expression Levels of Mir-21-5P and Mir-429 Genes in Biopsy Samples From Patients With Oral Squamous Cell Carcinoma. Diagnostics. 2023;13(7):-. |
BibTex | @article{ author = {Garajei A and Allameh A and Azadi M and Emami A and Atashbasteh M and Mostafavi M and Ghaderi B and Inchingolo F and Sadeghi M and Tadakamadla SK and Mohammadi H and Tadakamadla J}, title = {Evaluation of the Expression Levels of Mir-21-5P and Mir-429 Genes in Biopsy Samples From Patients With Oral Squamous Cell Carcinoma}, journal = {Diagnostics}, volume = {13}, number = {7}, pages = {-}, year = {2023} } |
RIS | TY - JOUR AU - Garajei A AU - Allameh A AU - Azadi M AU - Emami A AU - Atashbasteh M AU - Mostafavi M AU - Ghaderi B AU - Inchingolo F AU - Sadeghi M AU - Tadakamadla SK AU - Mohammadi H AU - Tadakamadla J TI - Evaluation of the Expression Levels of Mir-21-5P and Mir-429 Genes in Biopsy Samples From Patients With Oral Squamous Cell Carcinoma JO - Diagnostics VL - 13 IS - 7 SP - EP - PY - 2023 ER - |